Navigation Links
Chemotherapy Pill Has Fewer Side Effects Than IV,,

A chemotherapy pill is as effective for treating advanced colorectal cancer as intravenous treatment with a similar drug. Patients taking the pill capecitabine survived just as long as those on standard chemotherapy, but the pill caused fewer side effects.// Capecitabine is the oral form of 5-fluorouracil (5-FU), the chemotherapy regimen most commonly used to treat advanced colorectal cancer.

Capecitabine is both convenient to use and produces fewer side effects, and that's a big attraction for patients. Given these results, patients slated to receive the chemotherapy drug 5-FU could consider receiving it in pill form rather than through an IV.

Capecitabine, sold as Xeloda by New Jersey-based Roche Laboratories, has been approved by the FDA to treat breast cancer that has spread beyond the breast and is resistant to standard chemotherapy. Unlike intravenous 5-FU, which is active throughout the body, capecitabine is designed to target tumor cells directly.

Patients taking the oral drug were significantly more likely to respond to treatment than those on standard chemotherapy, and side effects, including diarrhoea, hair loss, nausea and gastrointestinal tract ulcers, were less common in patients taking the pill, particularly during the first few months of treatment. Patients in the capecitabine group were also less likely to be hospitalized due to side effects.
'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
3. Therapy Boosts Chemotherapy Effects
4. Chemotherapy Effective for Bladder Cancer
5. New Method Of Delivering Chemotherapy
6. The Benefits Of Chemotherapy For Women With Ovarian Cancer
7. New Compound Could Strengthen The Effect Of Chemotherapy
8. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
9. Treating Testicular Cancer With A Single Dose Of Chemotherapy
10. Ginger Found To Reduce Nausea Associated With Chemotherapy
11. AIDS Drug Found To Help Patients Undergoing Chemotherapy

Post Your Comments:
(Date:11/8/2009)...PRNewswire-USNewswire/ -- Speaker Nancy Pelosi and...ing the House passage of H.R. 3962, the Affordable...a vote of 220 to 215. Below are the Speaker,s ope...just received a call from the President of the Uni...reat victory for the American people. I thank the ...
(Date:11/8/2009)...3D Global Solutions is pleased to announce that it...sal effort for ReSound who recently received an aw...tract. The award includes not only the Veterans Ad...nd other federal agencies. , ...obal Solutions is pleased to announce that it has ...
(Date:11/8/2009)...A jury of 8 people in the Western District of Penn...n pain and suffering for a medical malpractice cas...icia Nocera of Thomas E. Crenney and Associates, L...ta Monestersky and against the Uniontown Hospital....al hysterectomy at age 18. , ...
(Date:11/8/2009)...twork of Hispanic health advocates committed to ac..., WASHINGTON, Nov. 7 "...hey have heard the voice of America,s families by .... Now the Senate must deliver, without delay, on t... Dr. Jane L. Delgado, President and CEO of the Nat...
(Date:11/8/2009)...sage of H.R. 3961 to Secure the Stability of Medic... -- Statement Attributable to: J. James Rohack, M.... (Logo: http://www.newscom.com/cgi-bin/prnh/2008...of the House health reform bill, which will help i...ns and calls for swift passage of H.R. 3961 to sec...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...n kid is exhibiting antisocial behaviour, breaking...attention , then the root cause could be the tende...ther than in the morning. The finding is b...s/eveningness', along with the ratio of cortisol r...
...Minogue earned an incredible 4.5million pounds in ... . Despite retreating from the public eye ... doubled her income from the preceding year. ...2.63 million pounds. The 39-year-old was d...
...ways handed over the new five state-of-the-art coa... a train, to Impact India Foundation here today. S... Shri Lalu Prasad said that since 1991, Impact Ind...iors of India where medical facilities are almost ...
...ss Lindsay Lohan's MySpace conversations with alle...aked . Apparently, the 'Mean Girls' star k...h the site and one of them gave Star magazine the ... the 21-year-old says that she wants to marry Rons...
...m the University of Pittsburgh School of Medicine ... an effective treatment for human liver cancer in... Using a newly available monoclonal antibody, ...ccording to the researchers, this finding has sign...
...risk caused by exposure to asbestos has prompted t...bestos . The society has rejected long-held federa...rt of the fire-retarding mineral still being mined... of the Canadian Cancer Society, said. The ...
Other Medicine News:Health News:Late Nights may Make Preteens Antisocial and Aggressive 2Health News:New Lifeline Express Train Inaugurated 2Health News:A New Monoclonal Antibody Kills Cancer Cells 2Health News:Canadian Cancer Society Calls for Ban on Asbestos 2
(Date:11/6/2009)... SCOLR Pharma, Inc. (Amex...three and nine months ended September 30, 2009. ...and CEO, said, "We continue to advance discussions...ation. Several potential partners have committed s...al resources as they evaluate the potential commer...
(Date:11/6/2009)...wswire-FirstCall/ -- Recession in domestic and int...Allied Healthcare Products in the first quarter of... Sales declines pushed Allied into a loss for the ...745,000, or negative 9 cents per share, compared t... or 3 cents per share. ,, Sales fell about 21 ...
(Date:11/6/2009)... 6 DUSA Pharmaceuticals,...pany that is developing and marketing Levulan(...focused on patients with common skin conditions, a...tive Officer, will present a corporate overview at...Tuesday, November 10, 2009 at 10:00 a.m. ET at the...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 1VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 2VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 3VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ 5420 4New old drug fights colon cancer 59359 1New old drug fights colon cancer 59359 2NIH awards more than 2454 Million to Kaiser Permanente to conduct health research 59355 1NIH awards more than 2454 Million to Kaiser Permanente to conduct health research 59355 2
...udies examining the effects of stem cell source an...s will be explored at a press conference taking pl...e 50th Annual Meeting of the American Society of H...s from a study examining a specialized technique f...lood for transplantation will also be shared durin...
...y assessing the quality of care for patients with ...ngs will be presented at a press conference on Sat...nnual Meeting of the American Society of Hematolog...ning methods that help determine stroke risk in ch...y examining the effects of long-term hydroxyurea u...
Other Medicine Technology:Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 2Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 3Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 4Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 5Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 6Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 7Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes 8Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 2Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 3Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 4Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 5Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 6Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 7Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 8Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder 9
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: